MXPA02008110A - Liposomas terapeuticos radioactivos. - Google Patents
Liposomas terapeuticos radioactivos.Info
- Publication number
- MXPA02008110A MXPA02008110A MXPA02008110A MXPA02008110A MXPA02008110A MX PA02008110 A MXPA02008110 A MX PA02008110A MX PA02008110 A MXPA02008110 A MX PA02008110A MX PA02008110 A MXPA02008110 A MX PA02008110A MX PA02008110 A MXPA02008110 A MX PA02008110A
- Authority
- MX
- Mexico
- Prior art keywords
- liposomes
- radioactive therapeutic
- therapeutic liposomes
- radioactive
- ionophores
- Prior art date
Links
- 239000002502 liposome Substances 0.000 title abstract 4
- 230000002285 radioactive effect Effects 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title 1
- LBDSXVIYZYSRII-IGMARMGPSA-N alpha-particle Chemical compound [4He+2] LBDSXVIYZYSRII-IGMARMGPSA-N 0.000 abstract 1
- 239000002738 chelating agent Substances 0.000 abstract 1
- 239000002555 ionophore Substances 0.000 abstract 1
- 230000000236 ionophoric effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- A61K51/1072—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from the reproductive system, e.g. ovaria, uterus, testes or prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
- A61K51/1234—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20000855A NO312708B1 (no) | 2000-02-21 | 2000-02-21 | Radioaktive liposomer til terapi |
PCT/NO2001/000065 WO2001060417A2 (en) | 2000-02-21 | 2001-02-21 | Radioactive therapeutic liposomes |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA02008110A true MXPA02008110A (es) | 2003-12-11 |
Family
ID=19910768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA02008110A MXPA02008110A (es) | 2000-02-21 | 2001-02-21 | Liposomas terapeuticos radioactivos. |
Country Status (21)
Country | Link |
---|---|
US (1) | US6592843B2 (es) |
EP (1) | EP1257299B9 (es) |
JP (1) | JP4933712B2 (es) |
KR (1) | KR100822566B1 (es) |
CN (1) | CN100350981C (es) |
AT (1) | ATE300316T1 (es) |
AU (2) | AU3782701A (es) |
BR (1) | BR0108572A (es) |
CA (1) | CA2400994C (es) |
CZ (1) | CZ299032B6 (es) |
DE (1) | DE60112251T2 (es) |
DK (1) | DK1257299T3 (es) |
EA (1) | EA005624B1 (es) |
ES (1) | ES2247069T3 (es) |
MX (1) | MXPA02008110A (es) |
NO (1) | NO312708B1 (es) |
NZ (1) | NZ520848A (es) |
PL (1) | PL201398B1 (es) |
UA (1) | UA73160C2 (es) |
WO (1) | WO2001060417A2 (es) |
ZA (1) | ZA200206500B (es) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO310544B1 (no) * | 1999-01-04 | 2001-07-23 | Algeta As | Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben |
NO314537B1 (no) * | 1999-12-06 | 2003-04-07 | Anticancer Therapeutic Inv Sa | Reseptorbindende konjugater |
US8029795B2 (en) * | 1999-12-30 | 2011-10-04 | Gwathmey, Inc. | Targeted iron chelator delivery system |
ES2312448T3 (es) * | 2000-06-16 | 2009-03-01 | Sloan-Kettering Institute For Cancer Research | Encapsulacion liposomica de emisores alfa y sus usos. |
US20040166060A1 (en) * | 2000-06-16 | 2004-08-26 | Sloan Kettering Institute For Cancer Research | Liposomal encapsulation of alpha particle emittors and uses thereof |
NO313180B1 (no) * | 2000-07-04 | 2002-08-26 | Anticancer Therapeutic Inv Sa | Bensökende alfapartikkel emitterende radiofarmasöytika |
US6869591B2 (en) * | 2002-03-26 | 2005-03-22 | Barnes-Jewish Hospital | Paramagnetic particles that provide improved relaxivity |
GB0213261D0 (en) * | 2002-06-10 | 2002-07-17 | Anticancer Therapeutic Inv Sa | Method |
GB0308731D0 (en) * | 2003-04-15 | 2003-05-21 | Anticancer Therapeutic Inv Sa | Method of radiotherapy |
KR20060015507A (ko) * | 2003-04-15 | 2006-02-17 | 알게타 에이에스 | 연조직 질환의 방사선 치료에 사용하기 위한 토륨-227 |
CA2536393A1 (en) * | 2003-09-09 | 2005-06-16 | Gilead Sciences, Inc. | Use of liposomes which are small unilamellar vesicles for the removal of an entity from a biological sample |
BRPI0507824A (pt) * | 2004-02-20 | 2007-07-10 | Algeta As | hidroxiapatita, processo para a preparação de um particulado de hidroxiapatita marcada com radionuclìdeo, composição farmacêutica, uso de hidroxiapatita e de um radionuclìdeo emissor de alfa ou um radionuclìdeo emissor de beta, dispositivo, e, método de tratamento radioquìmico de um ser humano ou de um indivìduo animal não humano necessitando do mesmo |
US20070053845A1 (en) * | 2004-03-02 | 2007-03-08 | Shiladitya Sengupta | Nanocell drug delivery system |
EP1722762A2 (en) * | 2004-03-02 | 2006-11-22 | Massachusetts Institute of Technology | Nanocell drug delivery system |
GB0423565D0 (en) * | 2004-10-22 | 2004-11-24 | Algeta As | Formulation |
US20090110633A1 (en) * | 2005-03-14 | 2009-04-30 | Shiladitya Sengupta | Nanocells for Diagnosis and Treatment of Diseases and Disorders |
US8709380B1 (en) * | 2006-02-07 | 2014-04-29 | Sirius Medicine, Llc | Targeting agents for enhancing radiation therapy |
US20070224115A1 (en) * | 2006-03-22 | 2007-09-27 | The Regents Of The University Of California | Polymeric chelators for radionuclide delivery systems |
CN101485629B (zh) * | 2008-01-16 | 2013-01-23 | 沈阳药科大学 | 一种给药系统及其制备方法 |
US20100178245A1 (en) * | 2009-01-13 | 2010-07-15 | Arnsdorf Morton F | Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites |
US20100178244A1 (en) * | 2009-01-13 | 2010-07-15 | Arnsdorf Morton F | Biocompatible Microbubbles to Deliver Radioactive Compounds to Tumors, Atherosclerotic Plaques, Joints and Other Targeted Sites |
WO2010135714A2 (en) | 2009-05-22 | 2010-11-25 | The Methodist Hospital Research Institute | Methods for modulating adipocyte expression using microrna compositions |
CA2768444A1 (en) | 2009-07-17 | 2011-01-20 | Rigshospitalet | Loading technique for preparing radionuclide and ionophore containing liposomes in which the ionophore is 2-hydroxyquionoline (carbostyril) or structurally related 2-hydroxyquinolines |
JP2011111438A (ja) * | 2009-11-30 | 2011-06-09 | Akita Univ | 有機金属錯体を有効成分として含有する抗がん剤 |
GB201002508D0 (en) | 2010-02-12 | 2010-03-31 | Algeta As | Product |
DK2651447T3 (en) * | 2010-12-14 | 2018-12-17 | Univ Denmark Tech Dtu | Capture of radionuclides in nanoparticle compositions |
GB201105298D0 (en) * | 2011-03-29 | 2011-05-11 | Algeta Asa | Pharmaceutical preparation |
DE102011079031A1 (de) * | 2011-07-12 | 2013-01-17 | Algeta Asa | Flüssigkeitsbehälter |
GB201208309D0 (en) | 2012-05-11 | 2012-06-27 | Algeta As | Complexes |
US20160022842A1 (en) | 2013-03-11 | 2016-01-28 | Wayne State University | Formation and uses of europium |
NO3061464T3 (es) * | 2015-02-26 | 2018-03-24 | ||
AU2016223475B2 (en) * | 2015-02-26 | 2021-04-08 | Sciencons AS | Radiopharmaceutical solutions with advantageous properties |
US9433690B1 (en) * | 2015-02-26 | 2016-09-06 | Sciencons AS | Radiopharmaceutical solutions with advantageous properties |
EP3111959B1 (en) * | 2015-07-03 | 2017-09-13 | Oncoinvent AS | Radiotherapeutic particles and suspensions |
WO2017162555A1 (en) | 2016-03-24 | 2017-09-28 | Bayer Pharma Aktiengesellschaft | Radio-pharmaceutical complexes |
CA3026900A1 (en) | 2016-06-10 | 2017-12-14 | Bayer Pharma Aktiengesellschaft | Radio-pharmaceutical complexes |
AU2017281649B2 (en) * | 2016-06-24 | 2023-07-27 | Sciencons AS | Preparation of 212Pb labeled monoclonal antibodies |
CN110603076A (zh) | 2017-05-11 | 2019-12-20 | 阿尔法陶医疗有限公司 | 用于近距离放射治疗装置的聚合物涂层 |
US11969485B2 (en) | 2018-04-02 | 2024-04-30 | Alpha Tau Medical Ltd. | Controlled release of radionuclides |
US20230072421A1 (en) | 2019-07-25 | 2023-03-09 | Bayer As | Targeted radiopharmaceuticals for the diagnosis and treatment of prostate cancer |
CA3202211A1 (en) | 2020-12-16 | 2022-06-23 | Alpha Tau Medical Ltd. | Diffusing alpha-emitters radiation therapy with enhanced beta treatment |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4310506A (en) * | 1979-02-22 | 1982-01-12 | California Institute Of Technology | Means of preparation and applications of liposomes containing high concentrations of entrapped ionic species |
DK482685D0 (da) * | 1984-10-22 | 1985-10-21 | Hope Nat Medical Center | Fremgangsmaade til tilfoersel af micellulaere partikler, der indkapslerbilleddannende og kemoterapeutiske midler, til tumorer i et legeme |
EP0386146B1 (en) * | 1987-11-04 | 1993-04-28 | Vestar, Inc. | Composition and method of use for liposome encapsulated compounds for neutron capture tumor therapy |
US5527528A (en) * | 1989-10-20 | 1996-06-18 | Sequus Pharmaceuticals, Inc. | Solid-tumor treatment method |
EP1138334A3 (en) * | 1992-06-09 | 2002-04-03 | Neorx Corporation | Pretargeting methods and compounds |
GB9420390D0 (en) * | 1994-10-10 | 1994-11-23 | Nycomed Salutar Inc | Liposomal agents |
JP5064608B2 (ja) * | 1998-05-26 | 2012-10-31 | スローン−ケッタリング インスティトゥート フォー カンサー リサーチ | アルファ粒子放出構成物およびその使用方法 |
-
2000
- 2000-02-21 NO NO20000855A patent/NO312708B1/no not_active IP Right Cessation
-
2001
- 2001-02-21 KR KR1020027010848A patent/KR100822566B1/ko not_active IP Right Cessation
- 2001-02-21 CZ CZ20023164A patent/CZ299032B6/cs not_active IP Right Cessation
- 2001-02-21 NZ NZ520848A patent/NZ520848A/en not_active IP Right Cessation
- 2001-02-21 UA UA2002086850A patent/UA73160C2/uk unknown
- 2001-02-21 DK DK01910251T patent/DK1257299T3/da active
- 2001-02-21 EP EP01910251A patent/EP1257299B9/en not_active Expired - Lifetime
- 2001-02-21 ES ES01910251T patent/ES2247069T3/es not_active Expired - Lifetime
- 2001-02-21 WO PCT/NO2001/000065 patent/WO2001060417A2/en active IP Right Grant
- 2001-02-21 AU AU3782701A patent/AU3782701A/xx active Pending
- 2001-02-21 EA EA200200793A patent/EA005624B1/ru not_active IP Right Cessation
- 2001-02-21 AT AT01910251T patent/ATE300316T1/de active
- 2001-02-21 JP JP2001559512A patent/JP4933712B2/ja not_active Expired - Fee Related
- 2001-02-21 US US09/790,260 patent/US6592843B2/en not_active Expired - Lifetime
- 2001-02-21 CN CNB018053726A patent/CN100350981C/zh not_active Expired - Fee Related
- 2001-02-21 CA CA002400994A patent/CA2400994C/en not_active Expired - Fee Related
- 2001-02-21 BR BR0108572-7A patent/BR0108572A/pt not_active IP Right Cessation
- 2001-02-21 PL PL358541A patent/PL201398B1/pl unknown
- 2001-02-21 DE DE60112251T patent/DE60112251T2/de not_active Expired - Lifetime
- 2001-02-21 MX MXPA02008110A patent/MXPA02008110A/es active IP Right Grant
- 2001-02-21 AU AU2001237827A patent/AU2001237827B2/en not_active Ceased
-
2002
- 2002-08-14 ZA ZA200206500A patent/ZA200206500B/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3782701A (en) | Radioactive therapeutic liposomes | |
GB0105772D0 (en) | Use | |
AU5984701A (en) | Method of treating immune pathologies with low dose estrogen | |
MXPA04009163A (es) | Nuevos compuestos. | |
IL161187A0 (en) | Liposome compositions containing metal ions and therapeutic agents | |
HUP0105154A2 (hu) | Cluster típusú fejfájás kezelésére alkalmas görcsoldószármazékok | |
HUP0105489A2 (hu) | Kit fehérjék ittrium-90-nel való jelölésére | |
NZ522368A (en) | Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase | |
DE59800935D1 (en) | Immuntolerante prothrombinkomplex-präparation | |
AP2002002546A0 (en) | Iron chelator delivery system. | |
AU2001249684A1 (en) | Nasal administration of agents for the treatment of gastroparesis | |
HK1029932A1 (en) | Use of mirtazapine for the manufacture of a medicament for treating sleep apneas. | |
MX9700245A (es) | Nuevo compuesto quimico, su preparacion y su empleo como medicamento. | |
MY121523A (en) | Resorcinol derivatives | |
IL150367A0 (en) | Method for the preparation of citalopram | |
MY137580A (en) | Radioactive therapeutic liposomes | |
ZA200303045B (en) | Inhalable formulation of a solution containing a tiotropium salt. | |
GB9929485D0 (en) | Tramadol salts thereof and process for their preparation | |
GR3036481T3 (en) | Medicament containing delta-aminolevulinic acid | |
YU112585A (en) | Process for obtaining l-norcarnitine hydro-chloride | |
UA30267A (uk) | Протирикетсійний фітозасіб | |
UA30266A (uk) | Протихламідійний фітозасіб | |
UA29276A (uk) | Спосіб моделювання системного аутоімунного захворювання | |
UA33683A (uk) | Спосіб лікування поліпозного риносинуїту | |
UA37377A (uk) | Спосіб отримання мазі для лікування захворювань, які викликані внутрішньоклітинними інфекційними агентами |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |